CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
-2.21%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$2.99B
AUM Growth
+$2.99B
(+30%)
Cap. Flow
+$736M
Cap. Flow
% of AUM
24.63%
Top 10 Holdings %
Top 10 Hldgs %
55.98%
Holding
49
New
7
Increased
18
Reduced
7
Closed
5
Top Buys
| 1 |
Sanofi
SNY
|
$133M |
| 2 |
Universal Health Services
UHS
|
$133M |
| 3 |
Charles River Laboratories
CRL
|
$98.4M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$94.3M |
| 5 |
GSK
GSK
|
$73.6M |
Top Sells
| 1 |
BioMarin Pharmaceuticals
BMRN
|
$59.3M |
| 2 |
Sarepta Therapeutics
SRPT
|
$38.7M |
| 3 |
Ionis Pharmaceuticals
IONS
|
$34.3M |
| 4 |
Evolent Health
EVH
|
$30.7M |
| 5 |
Incyte
INCY
|
$30M |
Sector Composition
| 1 | Healthcare | 96.56% |
| 2 | Technology | 2.14% |
| 3 | Consumer Discretionary | 0.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Sanofi
SNY
$121B
| $285M | 8.73% | 7,500,000 +3,500,000 | +88% | +$133M |
|
2
Viatris
VTRS
$12.3B
| $256M | 7.83% | 30,000,000 +7,000,000 | +30% | +$59.6M |
|
|
3
Universal Health Services
UHS
$11.6B
| $198M | 6.08% | 2,250,000 +1,505,000 | +202% | +$133M |
|
|
4
Sarepta Therapeutics
SRPT
$1.78B
| $166M | 5.08% | 1,500,000 -350,000 | -19% | -$38.7M |
|
5
Tenet Healthcare
THC
$16.3B
| $155M | 4.74% | 3,000,000 +1,350,000 | +82% | +$69.6M |
|
6
Zimmer Biomet
ZBH
$21B
| $146M | 4.48% | 1,400,000 +50,000 | +4% | +$5.23M |
|
|
MRTX
7
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $140M | 4.28% | 2,000,000 +1,350,000 | +208% | +$94.3M |
|
8
PTC Therapeutics
PTCT
$3.92B
| $123M | 3.77% | 2,450,000 | – | – |
|
9
Select Medical
SEM
$1.61B
| $106M | 3.25% | 4,800,000 +800,000 | +20% | +$17.7M |
|
|
10
Charles River Laboratories
CRL
$8.04B
| $98.4M | 3.01% | +500,000 | New | +$98.4M |
|
11
Myriad Genetics
MYGN
$593M
| $95.4M | 2.92% | 5,000,000 | – | – |
|
12
Perrigo
PRGO
$3.27B
| $89.2M | 2.73% | 2,500,000 -250,000 | -9% | -$8.92M |
|
|
WBA
13
DELISTED
Walgreens Boots Alliance
WBA
| $88.7M | 2.72% | 2,825,000 | – | – |
|
|
14
Ionis Pharmaceuticals
IONS
$6.8B
| $85.1M | 2.61% | 1,925,000 -775,000 | -29% | -$34.3M |
|
|
15
GSK
GSK
$79.9B
| $73.6M | 2.25% | +2,500,000 | New | +$73.6M |
|
16
Brookdale Senior Living
BKD
$1.83B
| $68.3M | 2.09% | 16,000,000 | – | – |
|
|
17
BioMarin Pharmaceuticals
BMRN
$11.2B
| $67.8M | 2.08% | 800,000 -700,000 | -47% | -$59.3M |
|
|
CHNG
18
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $63.9M | 1.96% | 2,325,000 | – | – |
|
19
Teva Pharmaceuticals
TEVA
$21.1B
| $60.5M | 1.85% | 7,500,000 +4,750,000 | +173% | +$38.3M |
|
20
Biogen
BIIB
$19.4B
| $53.4M | 1.64% | 200,000 +75,000 | +60% | +$20M |
|
|
21
Incyte
INCY
$16.5B
| $50M | 1.53% | 750,000 -450,000 | -38% | -$30M |
|
|
CANO
22
DELISTED
Cano Health, Inc.
CANO
| $43.4M | 1.33% | 5,000,000 +2,000,000 | +67% | +$17.3M |
|
23
QuidelOrtho
QDEL
$1.95B
| $42.9M | 1.31% | +600,000 | New | +$42.9M |
|
24
Align Technology
ALGN
$10.3B
| $41.4M | 1.27% | 200,000 +100,000 | +100% | +$20.7M |
|
25
Medtronic
MDT
$119B
| $40.4M | 1.24% | +500,000 | New | +$40.4M |
|